文献速递母胎医学产科

中枢神经系统异常胎儿的产前外显子组测序分析

Prenatal exome sequencing analysis in fetuses with central nervous system anomalies.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

这项回顾性队列研究纳入167例产前超声和/或磁共振成像发现中枢神经系统异常的胎儿,均先行染色体微阵列分析(CMA),CMA阴性者接受产前外显子组测序(pES)。42例(25.1%)检出致病或可能致病变异;非孤立性中枢神经系统异常胎儿的诊断率显著高于单一中枢神经系统异常胎儿(35.7% vs 14.5%,P=0.010);pES结果显著影响父母终止妊娠的决策。

要点

  • CMA阴性且超声和/或MRI发现中枢神经系统异常的胎儿中,pES检出致病或可能致病变异比例为25.1%(42/167)。
  • 非孤立性中枢神经系统异常胎儿的pES诊断率显著高于单一中枢神经系统异常胎儿(35.7% vs 14.5%,P=0.010)。
  • 胎儿携带致病或可能致病变异时,父母选择 advanced pregnancy termination 的比例显著高于意义未明变异、次要/偶然发现或pES阴性者(83.3% vs 41.3%,P<0.001)。

核心结论

  • pES提高了CMA未发现染色体异常或拷贝数变异的中枢神经系统异常胎儿的遗传病检出率,无论中枢神经系统异常数目及是否合并颅外异常。
  • pES结果可显著影响父母的决策。

研究设计与样本

  • 回顾性队列研究,纳入产前超声和/或磁共振成像发现中枢神经系统异常的胎儿167例。
  • 所有胎儿先行CMA分析;CMA确诊非整倍体或致病性拷贝数变异者不进行pES并排除,CMA阴性者接受pES检测。

主要发现

  • 167例妊娠中42例(25.1%)检出致病或可能致病变异。
  • 非孤立性中枢神经系统异常胎儿诊断率为35.7%(20/56),单一中枢神经系统异常胎儿为14.5%(8/55),差异有统计学意义(P=0.010)。
  • 胎儿存在三个或以上中枢神经系统异常时,阳性诊断率增至42.9%。
  • 42例中25例(59.5%)为新发突变,其余为遗传性突变且再发风险显著。

关键数值与推荐

  • 胎儿携带致病或可能致病突变时,父母选择 advanced pregnancy termination 的比例为83.3%(25/30),显著高于意义未明变异、次要/偶然发现或pES阴性者的41.3%(38/92)(P<0.001)。

临床怎么用

  • 对于CMA阴性的中枢神经系统异常胎儿,可提供pES检测以辅助遗传学诊断。
  • pES结果可用于父母决策咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the utility of prenatal exome sequencing (pES) in fetuses with central nervous system (CNS) abnormalities. METHODS: This was a retrospective cohort study of fetuses identified to have CNS abnormality on prenatal ultrasound and/or magnetic resonance imaging. All fetuses were first analyzed by chromosomal microarray analysis (CMA). Fetuses with a confirmed aneuploidy or causal pathogenic copy-number variant (CNV) on CMA did not undergo pES analysis and were excluded, while those with a negative CMA result were offered pES testing. RESULTS: Of the 167 pregnancies included in the study, 42 (25.1%) were identified to have a pathogenic or likely pathogenic (P/LP) variant. The diagnostic rate was significantly higher in fetuses with a non-isolated CNS abnormality than in those with a single CNS abnormality (35.7% (20/56) vs 14.5% (8/55); P = 0.010). Moreover, when a fetus had three or more CNS abnormalities, the positive diagnostic rate increased to 42.9%. A total of 25/42 (59.5%) cases had de-novo mutations, while, in the remaining cases, mutations were inherited and carried a significant risk of recurrence. Families whose fetus carried a P/LP mutation were more likely to choose advanced pregnancy termination than those with a variant of uncertain significance, secondary/incidental finding or negative pES result (83.3% (25/30) vs 41.3% (38/92); P < 0.001). CONCLUSION: pES improved the identification of genetic disorders in fetuses with CNS anomalies without a chromosomal abnormality or CNV identified on CMA, regardless of the number of CNS anomalies and presence of extracranial abnormality. We also demonstrated that pES findings can significantly impact parental decision-making. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhi Y, Liu L, Wang H, et al. Prenatal exome sequencing analysis in fetuses with central nervous system anomalies. Ultrasound Obstet Gynecol. 2023. PMID: 37204857. doi:10.1002/uog.26254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。